BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11226817)

  • 1. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
    Gref R; Quellec P; Sanchez A; Calvo P; Dellacherie E; Alonso MJ
    Eur J Pharm Biopharm; 2001 Mar; 51(2):111-8. PubMed ID: 11226817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression.
    Sirc J; Hampejsova Z; Trnovska J; Kozlik P; Hrib J; Hobzova R; Zajicova A; Holan V; Bosakova Z
    Pharm Res; 2017 Jul; 34(7):1391-1401. PubMed ID: 28405914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres.
    Urata T; Arimori K; Nakano H
    J Control Release; 1999 Mar; 58(2):133-41. PubMed ID: 10053186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
    Ruan G; Feng SS
    Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
    Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
    J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
    Liu D; Wang L; Liu Z; Zhang C; Zhang N
    J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
    Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS
    J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
    Elvassore N; Bertucco A; Caliceti P
    J Pharm Sci; 2001 Oct; 90(10):1628-36. PubMed ID: 11745721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of hydrophilic poly(lactic acid) tissue engineering scaffold via (PLA)-(PLA-b-PEG)-(PEG) solution casting and thermal-induced surface structural transformation.
    Zhu X; Zhong T; Huang R; Wan A
    J Biomater Sci Polym Ed; 2015; 26(17):1286-96. PubMed ID: 26324121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
    Essa S; Louhichi F; Raymond M; Hildgen P
    J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
    Essa S; Rabanel JM; Hildgen P
    Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic nanoparticles-loaded PLA/PEG microspheres as drug carriers.
    Frounchi M; Shamshiri S
    J Biomed Mater Res A; 2015 May; 103(5):1893-8. PubMed ID: 25203941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
    Park SJ; Kim SH
    J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
    Mainardes RM; Khalil NM; Gremião MP
    Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
    Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
    J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.